Related Experiment Video
Updated: Apr 23, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Can we stop AIDS with antiretroviral-based treatment as prevention?
Edward J Mills1, Jean B Nachega2, Nathan Ford3
1Stanford Prevention Research Center, Stanford University , Stanford, CA , USA.
Abstract:
Challenges to scaling up treatment as prevention (TasP) of HIV transmission are considerable in the developing-world context and include accessing at-risk populations, human resource shortages, adherence and retention in care, access to newer treatments, measurement of treatment effects, and long-term sustainable funding. Optimism about ending AIDS needs to be tempered by the realities of the logistic challenges of strengthening health systems in countries most affected and by balancing TasP with overall combination prevention approaches.
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Inhibitors of Viral Protein Synthesis
Retroviruses
Preventive Healthcare Services
Size and Structure of Viral Genomes

